The Precision Medicine Alliance Scotland (PMAS) delivers on a Programme for Government commitment. The strategic aim of PMAS is to stimulate research and delivery in the NHS of Precision Medicine approaches to the treatment and management of health conditions of major importance in Scotland, including diseases that disproportionately impact those at risk of socioeconomic disadvantage.
The Scottish Government launched the PMAS funding call 27 May 2021, which was open for application from Scottish-led researchers. Following an independent expert review process 4 projects were funded with a total investment of nearly £10 million over 4 years.
Details of funded projects can be found below.
| Code | Title | Fellow/PI | Organisation | Funding Amount | Abstract | Final Summary |
| PMAS/21/01 | The iDiabetes Platform: Enhanced Phenotyping of patients with diabetes for Precision Diagnosis, Prognosis and Treatment. | Professor Ewan Pearson | NHS Tayside | £2,810,386 | PMAS/21/01 Abstract | Project Active |
| PMAS/21/06 | Precision-MS: Integrating precision metrics of brain health into early treatment of multiple sclerosis. | Professor David Hunt | NHS Lothian | £1,947,038 | PMAS/21/06 Abstract | Project Active |
| PMAS/21/07 | Centre for Precision Cell Therapy for the Liver. | Professor Stuart Forbes | NHS Lothian | £2,197,164 | PMAS/21/07 Abstract | Project Active |
| PMAS/21/08 | Time critical precision medicine for acute critical illness using treatable trait principles: Data enabled adaptive platform trial with embedded biological characterisation [TRAITS Program]. | Professor Manu Shankar-Hari | NHS Lothian | £2,795,158 | PMAS/21/08 Abstract | Project Active |